Mechanistically, five cancer-specific CSNK2 phosphotargets were identified in at least four or more cancer types: AKT, STAT3, RELA (NFkB), PTEN and TP53 (Table 1 with corresponding references in Table S1, Appendix 2; Fig. 1a). This evidence concerns the gene PTEN and cancer.